InVivo Therapeutics Holdings buy BiotechBee
Start price
10.01.23
/
50%
€2.16
Target price
31.12.25
€4.00
Performance (%)
-46.57%
End price
05.05.23
€1.15
Summary
This prediction ended on 05.05.23 with a price of €1.15. The BUY prediction by BiotechBee for InVivo Therapeutics Holdings performed very badly with a performance of -46.57%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InVivo Therapeutics Holdings | - | - | - | - |
| iShares Core DAX® | -0.372% | 8.404% | 6.759% | 47.912% |
| iShares Nasdaq 100 | 2.269% | 15.232% | 36.176% | 94.084% |
| iShares Nikkei 225® | 1.433% | 14.424% | 43.114% | 64.804% |
| iShares S&P 500 | 1.216% | 10.492% | 27.276% | 66.763% |
According to BiotechBee what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Invivo Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading InVivo Therapeutics Holdings
Buy beendet

